KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) EBT (2016 - 2025)

LifeMD (LFMD) has disclosed EBT for 14 consecutive years, with -$6.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 56.82% year-over-year to -$6.0 million, compared with a TTM value of -$13.5 million through Dec 2025, up 38.46%, and an annual FY2025 reading of -$10.2 million, up 54.88% over the prior year.
  • EBT was -$6.0 million for Q4 2025 at LifeMD, down from -$2.2 million in the prior quarter.
  • Across five years, EBT topped out at -$2.2 million in Q1 2025 and bottomed at -$18.0 million in Q4 2021.
  • Average EBT over 5 years is -$7.9 million, with a median of -$6.3 million recorded in 2024.
  • The sharpest move saw EBT tumbled 393.98% in 2021, then skyrocketed 76.52% in 2023.
  • Year by year, EBT stood at -$18.0 million in 2021, then skyrocketed by 51.51% to -$8.7 million in 2022, then surged by 67.98% to -$2.8 million in 2023, then tumbled by 37.67% to -$3.8 million in 2024, then plummeted by 56.82% to -$6.0 million in 2025.
  • Business Quant data shows EBT for LFMD at -$6.0 million in Q4 2025, -$2.2 million in Q3 2025, and -$3.0 million in Q2 2025.